Loading...

CHF Solutions

Nasdaq:CHFS
Snowflake Description

Adequate balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CHFS
Nasdaq
$7M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The last earnings update was 39 days ago. More info.


Add to Portfolio Compare Print
  • CHF Solutions has significant price volatility in the past 3 months.
CHFS Share Price and Events
7 Day Returns
1.3%
NasdaqCM:CHFS
0.7%
US Medical Equipment
0.5%
US Market
1 Year Returns
-91.9%
NasdaqCM:CHFS
12.2%
US Medical Equipment
0.8%
US Market
CHFS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CHF Solutions (CHFS) 1.3% -16.8% -24.3% -91.9% -99.9% -100%
US Medical Equipment 0.7% 5% 1.5% 12.2% 63.1% 94.2%
US Market 0.5% -0.1% 1% 0.8% 37.5% 37.5%
1 Year Return vs Industry and Market
  • CHFS underperformed the Medical Equipment industry which returned 12.2% over the past year.
  • CHFS underperformed the Market in United States of America which returned 0.8% over the past year.
Price Volatility
CHFS
Industry
5yr Volatility vs Market

Value

 Is CHF Solutions undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for CHF Solutions. This is due to cash flow or dividend data being unavailable. The share price is $3.06.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CHF Solutions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CHF Solutions's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:CHFS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-41.09
NasdaqCM:CHFS Share Price ** NasdaqCM (2019-06-14) in USD $3.06
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 40.75x
United States of America Market PE Ratio Median Figure of 3,094 Publicly-Listed Companies 17.69x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CHF Solutions.

NasdaqCM:CHFS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:CHFS Share Price ÷ EPS (both in USD)

= 3.06 ÷ -41.09

-0.07x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CHF Solutions is loss making, we can't compare its value to the US Medical Equipment industry average.
  • CHF Solutions is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does CHF Solutions's expected growth come at a high price?
Raw Data
NasdaqCM:CHFS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.07x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
43.3%per year
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.25x
United States of America Market PEG Ratio Median Figure of 2,125 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for CHF Solutions, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on CHF Solutions's assets?
Raw Data
NasdaqCM:CHFS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $6.06
NasdaqCM:CHFS Share Price * NasdaqCM (2019-06-14) in USD $3.06
United States of America Medical Equipment Industry PB Ratio Median Figure of 183 Publicly-Listed Medical Equipment Companies 4.36x
United States of America Market PB Ratio Median Figure of 5,244 Publicly-Listed Companies 1.79x
NasdaqCM:CHFS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:CHFS Share Price ÷ Book Value per Share (both in USD)

= 3.06 ÷ 6.06

0.51x

* Primary Listing of CHF Solutions.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CHF Solutions is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess CHF Solutions's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. CHF Solutions has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is CHF Solutions expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
43.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CHF Solutions expected to grow at an attractive rate?
  • Unable to compare CHF Solutions's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare CHF Solutions's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • CHF Solutions's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:CHFS Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:CHFS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 43.3%
NasdaqCM:CHFS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 47.4%
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.9%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.9%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:CHFS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:CHFS Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 35 -1 1
2021-12-31 25 -8 1
2020-12-31 15 -12 -13 1
2019-12-31 7 -16 -17 1
NasdaqCM:CHFS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 5 -14 -22
2018-12-31 5 -15 -17
2018-09-30 4 -15 -29
2018-06-30 4 -15 -27
2018-03-31 4 -15 -27
2017-12-31 4 -12 -25
2017-09-30 3 -11 -14
2017-06-30 3 -13 -15
2017-03-31 2 -12 -16
2016-12-31 1 -16 -18
2016-09-30 1 -18 -19
2016-06-30 0 -19 -22

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • CHF Solutions is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • CHF Solutions's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:CHFS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from CHF Solutions Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CHFS Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 -0.15 -0.15 -0.15 1.00
2021-12-31 -0.95 -0.95 -0.95 1.00
2020-12-31 -2.38 -2.38 -2.38 1.00
2019-12-31 -5.53 -5.53 -5.53 1.00
NasdaqCM:CHFS Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -41.09
2018-12-31 -42.16
2018-09-30 -93.85
2018-06-30 -142.18
2018-03-31 -223.95
2017-12-31 -520.25
2017-09-30 -699.22
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if CHF Solutions will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess CHF Solutions's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CHF Solutions has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has CHF Solutions performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CHF Solutions's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • CHF Solutions does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare CHF Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare CHF Solutions's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
CHF Solutions's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CHF Solutions Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CHFS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 5.18 -21.91 15.32 3.88
2018-12-31 5.00 -17.03 15.31 3.05
2018-09-30 4.33 -28.65 14.18 2.59
2018-06-30 3.92 -27.26 13.14 1.97
2018-03-31 3.69 -26.56 11.79 1.65
2017-12-31 3.55 -24.97 10.17 1.48
2017-09-30 3.47 -13.90 10.16 1.60
2017-06-30 3.05 -14.97 9.28 2.97
2017-03-31 2.19 -15.67 8.27 5.21
2016-12-31 1.29 -17.69 7.23 8.11
2016-09-30 0.54 -19.50 6.63 11.78
2016-06-30 0.00 -22.14 6.57 14.59
2016-03-31 0.00 -24.31 7.51 16.01
2015-12-31 0.06 -26.58 8.35 17.67
2015-09-30 0.24 -26.72 8.50 17.99
2015-06-30 0.30 -26.30 9.14 17.25
2015-03-31 0.30 -26.32 9.03 17.68
2014-12-31 0.30 -25.59 9.21 16.87
2014-09-30 0.12 -25.95 9.78 16.47
2014-06-30 0.12 -25.85 9.90 16.40
2014-03-31 0.12 -23.69 9.81 15.14
2013-12-31 0.06 -21.76 9.43 13.50
2013-09-30 0.06 -18.72 8.47 11.57
2013-06-30 -15.98 7.48 9.63
2013-03-31 -14.38 6.90 8.26
2012-12-31 -14.07 6.87 8.00
2012-09-30 -15.23 7.12 9.02
2012-06-30 -16.61 7.05 10.49

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if CHF Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if CHF Solutions has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if CHF Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess CHF Solutions's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CHF Solutions has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is CHF Solutions's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CHF Solutions's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • CHF Solutions is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • CHF Solutions's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of CHF Solutions's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are -1.2836159657931E+17x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CHF Solutions Company Filings, last reported 2 months ago.

NasdaqCM:CHFS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 12.53 0.57 11.49
2018-12-31 5.94 0.00 5.48
2018-09-30 9.65 0.00 8.22
2018-06-30 8.81 0.00 7.00
2018-03-31 12.39 0.00 10.50
2017-12-31 16.24 0.00 15.60
2017-09-30 6.98 0.00 2.51
2017-06-30 9.51 0.00 5.56
2017-03-31 3.85 0.00 1.66
2016-12-31 2.24 0.00 1.32
2016-09-30 2.46 0.00 0.79
2016-06-30 3.69 5.90 12.05
2016-03-31 7.61 6.80 16.47
2015-12-31 12.17 7.68 23.11
2015-09-30 18.44 7.75 27.90
2015-06-30 24.52 7.70 33.42
2015-03-31 30.07 5.75 37.03
2014-12-31 29.22 0.00 31.29
2014-09-30 35.06 0.00 36.58
2014-06-30 40.52 0.00 42.13
2014-03-31 46.21 0.00 47.42
2013-12-31 51.73 0.00 54.14
2013-09-30 57.86 0.00 59.81
2013-06-30 20.39 0.00 21.53
2013-03-31 9.90 0.00 10.97
2012-12-31 12.95 0.00 14.22
2012-09-30 16.34 0.00 17.45
2012-06-30 0.65 0.00 1.77
  • CHF Solutions's level of debt (0%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (0% vs 0% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • CHF Solutions has less than a year of cash runway based on current free cash flow.
  • CHF Solutions has less than a year of cash runway if free cash flow continues to reduce at historical rates of -11% each year.
X
Financial health checks
We assess CHF Solutions's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CHF Solutions has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is CHF Solutions's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from CHF Solutions dividends.
If you bought $2,000 of CHF Solutions shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate CHF Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate CHF Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:CHFS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2011 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:CHFS Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as CHF Solutions has not reported any payouts.
  • Unable to verify if CHF Solutions's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of CHF Solutions's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as CHF Solutions has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CHF Solutions's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CHF Solutions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CHF Solutions has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of CHF Solutions's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Erb
COMPENSATION $2,639,169
AGE 69
TENURE AS CEO 3.6 years
CEO Bio

Mr. John L. Erb has been the Chief Executive Officer and President of CHF Solutions, Inc. (also known as Sunshine Heart Inc.) since November 2015. He has been Chairman of CHF Solutions, Inc. since September 12, 2012. Mr. Erb is the Co-founder of NuAx, Inc. and serves as its Chairman (during 2007) and served as its Chief Executive Officer from 2001 to 2006 of the previous owner of the Aquadex FlexFlow System. He is Senior Advisor at Wombat Capital and Medical Device Cardio Vascular. He serves as an Advisor at Brightstone Venture Capital. He focuses on healthcare. He served as Interim Chief Executive Officer and Interim President of Sunshine Heart Inc. since November 30, 2015 until March 2, 2016. Mr. Erb served as Chief Executive Officer of Harbinger Medical Inc. He served as President and Chief Executive Officer at Sulzer IntraTherapeutics Inc. from 1997 to 2001. He has over 35 years of experience in the medical device industry with both device companies such as American Hospital Supply Corp., Cutter Laboratories, Inc., Johnson & Johnson and Pfizer; and venture capital financed start-up companies. Mr. Erb served as Vice President of Worldwide Operations of Schneider Worldwide, a division of Pfizer, Inc. from 1991 to 1997. He served as General Manager of Schneider U.S. Stent Division. Mr. Erb has also built two venture capital financed medical device companies; IntraTherapeutics, Inc., a peripheral vascular stent company acquired by Sulzer Medical in 2001 and now the primary stent product-line of Covidien’s EV3 division; and CHF Solutions, Inc., acquired by Gambro Renal Products in January 2010. Mr. Erb served as Chief Executive Officer and President at CHF Solutions, Inc. He serves as Non-Executive Chairman at Osprey Medical Inc. He served as Chairman of Vascular Solutions, Inc. since May 2011 until February 17, 2017 and its Director since October 2002 until February 17, 2017. He served as Chairman of CHF Solutions, Inc. since January 2007. He served as Chairman of Munson Healthcare, Inc. and VivoMetrics, Inc. He served as Chairman of Board of Trustees of Munson Medical Center. Mr. Erb also serves on the Board of Directors for CHF Solutions, Inc. since September 2012. He also serves on the Board of CloSys Corporation and AUM Cardiovascular. He serves as Scientific Advisor of Q BioMed Inc. He has been Director of Osprey Medical Inc. since June 2007 and Vascular Solutions Inc. since October 2002. He serves as Director at Harbinger Medical Inc. He served as an Independent Director at SenoRx, Inc., from December 2001 to July 2010. He served as a Director of Xoft, Inc. and CryoCath Technologies, Inc. (from October 2000 to December 2008). He served as a Director of Medtronic CryoCath LP. Mr. Erb has a Bachelor’s degree in Business Administration, with a concentration in Finance from California State University at Fullerton.

CEO Compensation
  • John's compensation has increased whilst company is loss making.
  • John's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the CHF Solutions management team in years:

0.8
Average Tenure
50.5
Average Age
  • The average tenure for the CHF Solutions management team is less than 2 years, this suggests a new team.
Management Team

John Erb

TITLE
Chairman
COMPENSATION
$3M
AGE
69
TENURE
3.6 yrs

Claudia Drayton

TITLE
Chief Financial Officer
COMPENSATION
$978K
AGE
50
TENURE
4.4 yrs

Vitaliy Epshteyn

TITLE
Sr. Vice President of Operations & Engineering
AGE
40
TENURE
1.4 yrs

David Lerner

TITLE
Sr. Vice President of Corporate Development & Technology
TENURE
0.3 yrs

Thomas Lynch

TITLE
VP, General Counsel
AGE
51
TENURE
0.8 yrs

Sandra Eayrs

TITLE
Vice President of Human Resources
TENURE
4.4 yrs

Carrie Powers

TITLE
Senior Vice President of Commercial Operations
AGE
43
TENURE
0.7 yrs

Nestor Jaramillo

TITLE
Chief Commercial Officer
AGE
61
TENURE
0.1 yrs

Laurent Duhoux

TITLE
Vice President of International Business Development
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the CHF Solutions board of directors in years:

6.3
Average Tenure
65.5
Average Age
  • The tenure for the CHF Solutions board of directors is about average.
Board of Directors

John Erb

TITLE
Chairman
COMPENSATION
$3M
AGE
69
TENURE
6.7 yrs

Greg Waller

TITLE
Director
COMPENSATION
$246K
AGE
68
TENURE
7.8 yrs

Warren Watson

TITLE
Lead Independent Director
COMPENSATION
$226K
AGE
66

Jon Salveson

TITLE
Non Executive Director
COMPENSATION
$226K
AGE
53
TENURE
6.3 yrs

Steve Brandt

TITLE
Non-Executive Director
COMPENSATION
$186K
AGE
62
TENURE
2.3 yrs

Matt Likens

TITLE
Non-Executive Director
COMPENSATION
$186K
AGE
65
TENURE
2.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
12. Mar 19 Buy John Erb Individual 12. Mar 19 12. Mar 19 9,523 $5.25 $49,996
13. Aug 18 Sell Gregory Waller Individual 10. Aug 18 10. Aug 18 -5 $14.47 $-74
06. Jul 18 Buy John Erb Individual 03. Jul 18 03. Jul 18 1,685 $29.68 $49,998
X
Management checks
We assess CHF Solutions's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CHF Solutions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is CHF Solutions, Inc. (NASDAQ:CHFS) Spending Too Much Money?

(NASDAQ:CHFS) shareholders, and potential investors, need to understand how much cash the business makes from its core operational activities, as well as how much is invested back into the business. … Free cash flow (FCF) is the amount of cash CHF Solutions has left after it pays off its expenses, including its net capital expenditures, which is what the company needs to spend each year to maintain or grow its business operations. … The two ways to assess whether CHF Solutions’s FCF is sufficient, is to compare the FCF yield to the market index yield, as well as determine whether the top-line operating cash flows will continue to grow

Simply Wall St -

How Financially Strong Is CHF Solutions, Inc. (NASDAQ:CHFS)?

(NASDAQ:CHFS), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … However, the trade-off is CHFS will have to adhere to stricter debt covenants and have less financial flexibility. … Is CHFS growing fast enough to value financial flexibility over lower cost of capital

Simply Wall St -

What You Must Know About CHF Solutions Inc's (NASDAQ:CHFS) Market Risks

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … To use beta as an investor, you must first understand that the overall market has a beta of one. … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

Have Investors Priced In CHF Solutions Inc's (NASDAQ:CHFS) Growth?

saw significant share price volatility over the past couple of months on the NasdaqCM, rising to the highs of $4 and falling to the lows of $2.54. … A question to answer is whether CHF Solutions's current trading price of $2.67 reflective of the actual value of the? … Let’s take a look at CHF Solutions’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

Before You Buy CHF Solutions Inc's (NASDAQ:CHFS), Consider This

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … CHF Solutions has a beta of 2.25, which means that the percentage change in its stock value will be higher than the entire market in times of booms and busts. … A high level of beta means investors face higher risk associated with potential gains and losses driven by market movements.

Simply Wall St -

Have You Considered This Before Investing In CHF Solutions Inc (NASDAQ:CHFS)?

CHF Solutions’s free cash flow (FCF) is the level of cash flow the business generates from its operational activities, after it reinvests in the company as capital expenditure. … I will be analysing CHF Solutions’s FCF by looking at its FCF yield and its operating cash flow growth. … Free Cash Flow = Operating Cash Flows – Net Capital Expenditure Free Cash Flow Yield = Free Cash Flow / Enterprise Value where Enterprise Value = Market Capitalisation + Net Debt The business reinvests all its cash profits as well as borrows more money, to maintain and grow the company.

Simply Wall St -

CHF Solutions Inc's (NASDAQ:CHFS) Earnings Dropped -41.15%, Did Its Industry Show Weakness Too?

View our latest analysis for CHF Solutions How Did CHFS's Recent Performance Stack Up Against Its Past? … I like to use data from the most recent 12 months, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data. … For CHF Solutions, its latest earnings (trailing twelve month) is -US$24.97M, which, relative to the previous year's figure, has become more negative.

Simply Wall St -

What Are Analysts Saying About The Future Of CHF Solutions Inc's (NASDAQ:CHFS)?

CHF Solutions Inc's (NASDAQ:CHFS) released its most recent earnings update in December 2017, which confirmed company earnings became less negative compared to the previous year's level - great news for investors Investors may find it useful to understand how market analysts predict CHF Solutions's earnings growth trajectory over the next few years and whether the future looks brighter. … The slope of this line is the rate of earnings growth, which in this case is 67.94%. … Future Earnings: How does CHFS's growth rate compare to its peers and the wider market?

Simply Wall St -

Does CHF Solutions Inc's (NASDAQ:CHFS) CEO Salary Compare Well With Others?

I believe earnings is a cleaner proxy, since many factors can impact share price, and therefore, TSR. … Most recently, CHFS delivered negative earnings of -US$13.85M. … Typically I would look at market cap and earnings as a proxy for performance, however, CHFS's negative earnings lower the usefulness of my formula.

Simply Wall St -

What Does CHF Solutions Inc's (NASDAQ:CHFS) Share Price Indicate?

CHF Solutions Inc (NASDAQ:CHFS), a medical equipment company based in United States, saw a decent share price growth in the teens level on the NasdaqCM over the last few months. … Great news for investors – CHF Solutions is still trading at a fairly cheap price. … Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price.

Simply Wall St -

Company Info

Description

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company’s commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Details
Name: CHF Solutions, Inc.
CHFS
Exchange: NasdaqCM
Founded: 1999
$6,941,059
2,268,320
Website: http://www.chf-solutions.com
Address: CHF Solutions, Inc.
12988 Valley View Road,
Eden Prairie,
Minnesota, 55344,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM CHFS Ordinary Shares Nasdaq Capital Market US USD 16. Feb 2012
DB 22S3 Ordinary Shares Deutsche Boerse AG DE EUR 16. Feb 2012
Number of employees
Current staff
Staff numbers
55
CHF Solutions employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/17 00:35
End of day share price update: 2019/06/14 00:00
Last estimates confirmation: 2019/05/08
Last earnings filing: 2019/05/09
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.